Industry Updates for the Psychedelics World | Page 16 of 35

Psychedelics News

Industry

13 Dec 2022

Awakn’s Phase 3 Trial Launching With UK National Health Service

Awakn Life Sciences has announced that its Phase 3 trial using ketamine for Alcohol Use Disorder is going ahead in several sites across the UK....

By Jason Najum

Industry, Law & Politics

8 Dec 2022

Oregon’s Psilocybin Healing Centers: What You Need to Know

Psychedelic medicine advocates are anticipating the opening of Oregon’s legal psilocybin healing centers....

By James Hallifax

Industry

8 Dec 2022

Good Results for COMP360 Psilocybin in Bipolar Disorder Study

Positive study results of COMP360 psilocybin therapy in type II bipolar disorder and analysis of the phase 2b trial of COMP360 psilocybin therapy in treatment-resistant depression....

By Microdose NewsDesk

Industry

6 Dec 2022

Enthea Announces Nationwide Rollout: Psychedelic Therapy as Workplace Benefit

Enthea Announces Nationwide Rollout to Offer Psychedelic Therapy as a Workplace Benefit, Set to Launch into 40 U....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry, Press Releases

5 Dec 2022

MY Self Ketamine Clinic Launches Ketamine Access Nonprofit

MY Self Wellness Ketamine Clinic Launches Nonprofit Organization Warriors of Consciousness, Helping Those Who Cannot Afford Psychedelic Ketamine Therapy Treatments...

By Microdose

Industry, Science

30 Nov 2022

New MindMed Study Shortens Trip with “LSD-Neutralizer”

MindMed collaborators published a paper showing that the administration of ketanserin, effectively ends LSD’s psychedelic experience within 2....

By James Hallifax

Events, Industry

28 Nov 2022

The World on Drugs: Documentary Premiere at Wonderland

The World on Drugs is a documentary project produced by Microdose The filmmakers were joined by mushroom superstar Paul Stamets to discuss the film and its impact....

By Microdose

Industry

25 Nov 2022

When Will MDMA be Approved by the FDA?

Now that MAPS’ second Phase 3 trial has finished, it is only natural to ask the question: when will MDMA-assisted therapy for PTSD become legal?...

By James Hallifax

Industry

17 Nov 2022

MAPS Completes Second Phase 3 MDMA Trial

MAPS Completes Second Phase 3 "MAPP2" Trial of MDMA-Assisted Therapy for Treatment of PTSD...

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result